Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: A case series

BACKGROUND: Prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shedding has been described in immunocompromised coronavirus disease 2019 (COVID-19) patients, resulting in protracted disease and poor outcome. Specific therapy to improve viral clearance and outcome for this group o...

Descripción completa

Detalles Bibliográficos
Autores principales: van Laarhoven, Arjan, Kurver, Lisa, Overheul, Gijs J., Kooistra, Emma J., Abdo, Wilson F., van Crevel, Reinout, Duivenvoorden, Raphaël, Kox, Matthijs, ten Oever, Jaap, Schouten, Jeroen, van de Veerdonk, Frank L., van der Hoeven, Hans, Rahamat-Langendoen, Janette, van Rij, Ronald P., Pickkers, Peter, Netea, Mihai G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452508/
https://www.ncbi.nlm.nih.gov/pubmed/34568856
http://dx.doi.org/10.1016/j.medj.2021.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452508/
https://www.ncbi.nlm.nih.gov/pubmed/34568856
http://dx.doi.org/10.1016/j.medj.2021.09.003

Ejemplares similares